Granulocyte Transfusion during Cord Blood Transplant for Relapsed, Refractory AML Is Associated with Massive CD8⁺ T Cell Expansion, Significant Cytokine Release Syndrome and Induction of Disease Remission

Researchers reported the safety and tolerability of cord blood transplant recipients receiving granulocyte transfusions, T cell expansion data, immunophenotype, cytokine profiles and clinical response in children with post-transplant relapsed acute leukemia.